309 related articles for article (PubMed ID: 22965061)
1. Navigating cancer network attractors for tumor-specific therapy.
Creixell P; Schoof EM; Erler JT; Linding R
Nat Biotechnol; 2012 Sep; 30(9):842-8. PubMed ID: 22965061
[TBL] [Abstract][Full Text] [Related]
2. Cancer-related networks: a help to understand, predict and change malignant transformation.
Csermely P; Korcsmáros T
Semin Cancer Biol; 2013 Aug; 23(4):209-12. PubMed ID: 23831276
[TBL] [Abstract][Full Text] [Related]
3. Realizing Cancer Precision Medicine by Integrating Systems Biology and Nanomaterial Engineering.
Joo JI; Choi M; Jang SH; Choi S; Park SM; Shin D; Cho KH
Adv Mater; 2020 Sep; 32(35):e1906783. PubMed ID: 32253807
[TBL] [Abstract][Full Text] [Related]
4. Cancer systems biology: embracing complexity to develop better anticancer therapeutic strategies.
Du W; Elemento O
Oncogene; 2015 Jun; 34(25):3215-25. PubMed ID: 25220419
[TBL] [Abstract][Full Text] [Related]
5. Systems cancer medicine: towards realization of predictive, preventive, personalized and participatory (P4) medicine.
Tian Q; Price ND; Hood L
J Intern Med; 2012 Feb; 271(2):111-21. PubMed ID: 22142401
[TBL] [Abstract][Full Text] [Related]
6. Future of personalized medicine in oncology: a systems biology approach.
Gonzalez-Angulo AM; Hennessy BT; Mills GB
J Clin Oncol; 2010 Jun; 28(16):2777-83. PubMed ID: 20406928
[TBL] [Abstract][Full Text] [Related]
7. Cancer Systems Biology: a peek into the future of patient care?
Werner HM; Mills GB; Ram PT
Nat Rev Clin Oncol; 2014 Mar; 11(3):167-76. PubMed ID: 24492837
[TBL] [Abstract][Full Text] [Related]
8. Impact of genetic dynamics and single-cell heterogeneity on development of nonstandard personalized medicine strategies for cancer.
Beckman RA; Schemmann GS; Yeang CH
Proc Natl Acad Sci U S A; 2012 Sep; 109(36):14586-91. PubMed ID: 22891318
[TBL] [Abstract][Full Text] [Related]
9. Emerging functional markers for cancer stem cell-based therapies: Understanding signaling networks for targeting metastasis.
Marquardt S; Solanki M; Spitschak A; Vera J; Pützer BM
Semin Cancer Biol; 2018 Dec; 53():90-109. PubMed ID: 29966677
[TBL] [Abstract][Full Text] [Related]
10. Network, nodes and nexus: systems approach to multitarget therapeutics.
Murthy D; Attri KS; Gokhale RS
Curr Opin Biotechnol; 2013 Dec; 24(6):1129-36. PubMed ID: 23453398
[TBL] [Abstract][Full Text] [Related]
11. Precision medicine driven by cancer systems biology.
Filipp FV
Cancer Metastasis Rev; 2017 Mar; 36(1):91-108. PubMed ID: 28265786
[TBL] [Abstract][Full Text] [Related]
12. Personalized signaling models for personalized treatments.
Saez-Rodriguez J; Blüthgen N
Mol Syst Biol; 2020 Jan; 16(1):e9042. PubMed ID: 32129942
[TBL] [Abstract][Full Text] [Related]
13. Network and systems biology: essential steps in virtualising drug discovery and development.
Wierling C; Kessler T; Ogilvie LA; Lange BM; Yaspo ML; Lehrach H
Drug Discov Today Technol; 2015 Aug; 15():33-40. PubMed ID: 26464088
[TBL] [Abstract][Full Text] [Related]
14. Dynamic modeling and analysis of cancer cellular network motifs.
Cloutier M; Wang E
Integr Biol (Camb); 2011 Jul; 3(7):724-32. PubMed ID: 21674097
[TBL] [Abstract][Full Text] [Related]
15. Systems Medicine in Oncology: Signaling Network Modeling and New-Generation Decision-Support Systems.
Parodi S; Riccardi G; Castagnino N; Tortolina L; Maffei M; Zoppoli G; Nencioni A; Ballestrero A; Patrone F
Methods Mol Biol; 2016; 1386():181-219. PubMed ID: 26677185
[TBL] [Abstract][Full Text] [Related]
16. Introduction: Cancer Gene Networks.
Clarke R
Methods Mol Biol; 2017; 1513():1-9. PubMed ID: 27807826
[TBL] [Abstract][Full Text] [Related]
17. Adaptation and learning of molecular networks as a description of cancer development at the systems-level: potential use in anti-cancer therapies.
Gyurkó DM; Veres DV; Módos D; Lenti K; Korcsmáros T; Csermely P
Semin Cancer Biol; 2013 Aug; 23(4):262-9. PubMed ID: 23796463
[TBL] [Abstract][Full Text] [Related]
18. Principles of Resistance to Targeted Cancer Therapy: Lessons from Basic and Translational Cancer Biology.
Sabnis AJ; Bivona TG
Trends Mol Med; 2019 Mar; 25(3):185-197. PubMed ID: 30686761
[TBL] [Abstract][Full Text] [Related]
19. Inside the biochemical pathways of thymidylate synthase perturbed by anticancer drugs: Novel strategies to overcome cancer chemoresistance.
Taddia L; D'Arca D; Ferrari S; Marraccini C; Severi L; Ponterini G; Assaraf YG; Marverti G; Costi MP
Drug Resist Updat; 2015 Nov; 23():20-54. PubMed ID: 26690339
[TBL] [Abstract][Full Text] [Related]
20. Biologically Relevant Heterogeneity: Metrics and Practical Insights.
Gough A; Stern AM; Maier J; Lezon T; Shun TY; Chennubhotla C; Schurdak ME; Haney SA; Taylor DL
SLAS Discov; 2017 Mar; 22(3):213-237. PubMed ID: 28231035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
